These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 30712460

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.
    Seth A, Kitching R, Landberg G, Xu J, Zubovits J, Burger AM.
    Anticancer Res; 2003; 23(3A):2043-51. PubMed ID: 12894577
    [Abstract] [Full Text] [Related]

  • 3. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer.
    Elias EV, de Castro NP, Pineda PH, Abuázar CS, Bueno de Toledo Osorio CA, Pinilla MG, da Silva SD, Camargo AA, Silva WA, E Ferreira EN, Brentani HP, Carraro DM.
    Oncotarget; 2016 Nov 15; 7(46):75672-75684. PubMed ID: 27708222
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
    Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB.
    Breast Cancer Res Treat; 1999 May 15; 55(2):179-88. PubMed ID: 10481945
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.
    Breast Cancer Res; 2008 May 15; 10(5):R87. PubMed ID: 18928525
    [Abstract] [Full Text] [Related]

  • 8. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.
    Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, Graff JR.
    Cancer Res; 2000 Aug 15; 60(16):4346-8. PubMed ID: 10969774
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. p63 expression in normal, hyperplastic and malignant breast tissues.
    Wang X, Mori I, Tang W, Nakamura M, Nakamura Y, Sato M, Sakurai T, Kakudo K.
    Breast Cancer; 2002 Aug 15; 9(3):216-9. PubMed ID: 12185332
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.
    Barham W, Chen L, Tikhomirov O, Onishko H, Gleaves L, Stricker TP, Blackwell TS, Yull FE.
    BMC Cancer; 2015 Sep 30; 15():647. PubMed ID: 26424146
    [Abstract] [Full Text] [Related]

  • 16. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor.
    Lawrence JA, Merino MJ, Simpson JF, Manrow RE, Page DL, Steeg PS.
    Cancer Epidemiol Biomarkers Prev; 1998 Jan 30; 7(1):29-35. PubMed ID: 9456240
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade.
    Sowter HM, Ferguson M, Pym C, Watson P, Fox SB, Han C, Harris AL.
    J Pathol; 2003 Dec 30; 201(4):573-80. PubMed ID: 14648660
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.